Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Osoba

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1994
Inconsistency of prognostic factors for post-chemotherapy nausea and vomitingJ Pater, L Slamet, B Zee, et al.
Journal of the National Cancer Institute|February 6, 1991
Brief intensive chemotherapy for metastatic non-small-cell lung cancer: a phase II study of the weekly CODE regimenN Murray, D Osoba, A Shah, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 1, 1986
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapyD Osoba, C Erlichman, A R Willan, et al.
Journal of the National Cancer Institute|July 1, 1992
Quality-of-life assessment: patient compliance with questionnaire completionA Sadura, J Pater, D Osoba, et al.
The Canadian Journal of Oncology|September 1, 1995
Guidelines for the optimal management of chemotherapy-induced nausea and vomiting: a consensusD Osoba, D G Warr, M I Fitch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials GroupD Osoba, B Zee, J Pater, et al.
Cancer Treatment Reports|June 1, 1985
Phase II evaluation of bisantrene in patients with advanced renal cell carcinomaW K Evans, F A Shepherd, M E Blackstein, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1987
Imaging studies and the prognostic value of serum calcitonin in staging small-cell lung cancerT Samuels, R Cameron, H Hirte, et al.
Journal of Clinical Epidemiology|July 3, 1999
Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life QuestionnaireM R Stockler, D Osoba, P Corey, et al.
Cancer Treatment Reports|October 1, 1980
DTIC therapy in metastatic malignant melanoma: a simplified dose scheduleK I Pritchard, I C Quirt, D H Cowan, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 1, 1994
Inconsistency of prognostic factors for post-chemotherapy nausea and vomitingJ Pater, L Slamet, B Zee, et al.
Journal of the National Cancer Institute|February 6, 1991
Brief intensive chemotherapy for metastatic non-small-cell lung cancer: a phase II study of the weekly CODE regimenN Murray, D Osoba, A Shah, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 1, 1986
Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapyD Osoba, C Erlichman, A R Willan, et al.
Journal of the National Cancer Institute|July 1, 1992
Quality-of-life assessment: patient compliance with questionnaire completionA Sadura, J Pater, D Osoba, et al.
The Canadian Journal of Oncology|September 1, 1995
Guidelines for the optimal management of chemotherapy-induced nausea and vomiting: a consensusD Osoba, D G Warr, M I Fitch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials GroupD Osoba, B Zee, J Pater, et al.
Cancer Treatment Reports|June 1, 1985
Phase II evaluation of bisantrene in patients with advanced renal cell carcinomaW K Evans, F A Shepherd, M E Blackstein, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1987
Imaging studies and the prognostic value of serum calcitonin in staging small-cell lung cancerT Samuels, R Cameron, H Hirte, et al.
Journal of Clinical Epidemiology|July 3, 1999
Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life QuestionnaireM R Stockler, D Osoba, P Corey, et al.
Cancer Treatment Reports|October 1, 1980
DTIC therapy in metastatic malignant melanoma: a simplified dose scheduleK I Pritchard, I C Quirt, D H Cowan, et al.
Pageof 13